sellNotable cluster of 3
Shoshana Shendelman sold $4.7M of APLT
President and CEO at Applied Therapeutics, Inc.. 777,014 shares at an average of $6.06, traded Aug 12, 2024, filed Aug 14, 2024.
Warning score
70Value
$4.7M
777,014 shares
Holdings after
4,690,839
-14% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +25Trade size$4.7M at market
- +5Share of holdings soldSold 14% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-097309, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 5, 2024 | GGift Common Stockindirect: See footnote | -747,886 | $0.00 | $0 | 0 | Aug 14, 2024 |
| Aug 5, 2024 | GGift Common Stockindirect: See footnote | +747,886 | $0.00 | $0 | 747,886 | Aug 14, 2024 |
| Aug 12, 2024 | SOpen-market sale Common Stock | -300,000 | $5.98 | $1.8M | 5,167,853 | Aug 14, 2024 |
| Aug 13, 2024 | SOpen-market sale Common Stock | -357,423 | $6.18 | $2.2M | 4,810,430 | Aug 14, 2024 |
| Aug 14, 2024 | SOpen-market sale Common Stock | -119,591 | $5.93 | $709k | 4,690,839 | Aug 14, 2024 |
Related signals
Other insiders at Applied Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | APLTsell Applied Therapeutics, Inc. | Stacy J. Kanter director | $4,816 43,000 shares | -40% | |
| 30Weak | Applied Therapeutics, Inc. | Constantine Chinoporos See Remarks | $197 447 shares | -0% | |
| 30Weak | Applied Therapeutics, Inc. | Leslie D. Funtleyder See Remarks | $6,381 14,502 shares | -4% | |
| 30Weak | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $4,561 10,366 shares | -1% | |
| 30Weak | Applied Therapeutics, Inc. | Constantine Chinoporos See Remarks | $17k 28,117 shares | -9% | |
| 37Weak | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $53k 86,078 shares | -9% | |
| 30Weak | Applied Therapeutics, Inc. | Leslie D. Funtleyder See Remarks | $14k 22,950 shares | -5% | |
| 41Moderate | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $132k 22,681 shares | -2% | |
| 46Moderate | Applied Therapeutics, Inc. | Leslie D. Funtleyder Chief Financial Officer | $79k 13,530 shares | -5% | |
| 45Moderate | Applied Therapeutics, Inc. | Leslie D. Funtleyder Chief Financial Officer | $73k 16,980 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.